Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model

By sjmartinez • October 16, 2023

Iannone V, Babu AF, Lok J, Gómez-Gallego C, D'Auria G, Vazquez-Uribe R, Vaaben TH, Bongers M, Mikkonen S, Vaittinen M, Tikkanen I, Kettunen M, Klåvus A, Sehgal R, Kaminska D, Pihlajamaki J, Hanhineva K, El-Nezami H, Alexander Sommer MO, Kolehmainen M. Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model. Mol Metab. 2023 Oct 13:101823. doi: 10.1016/j.molmet.2023.101823. Epub ahead of print. PMID: 37839774.

Tags: aldafermin, Cardiology/Epi, genetically modified E. coli Nissle 1917, Metabolic dysfunction-associated steatotic liver disease, non-alcoholic fatty liver disease, non-targeted metabolomics, omics integration, Publications, Transcriptomics

Pregnancy Complications and Long-Term Atherosclerotic Cardiovascular Disease Risk

Rabadia SV, Heimberger S, Cameron NA, Shahandeh N. Pregnancy Complications and Long-Term Atherosclerotic Cardiovascular Disease Risk. Curr Atheroscler Rep. 2025 Jan 20;27(1):27. doi: 10.1007/s11883-024-01273-9. PMID:[...]

Alterations in genes associated with cytosolic RNA sensing in whole blood are associated with coronary microvascular disease in SLE

Huo L, Naveen Kumar A, Tumurkhuu G, Bose M, Berman DS, Wallace DJ, Wei J, Ishimori M, Bairey Merz CN, Jefferies C. Alterations in genes[...]

Racial disparities of type 2 diabetes through exercise: The Multi-Ethnic Study of Atherosclerosis

Xia T, Nianogo RA, Yu Q, Horwich T, Srikanthan P, Inoue K, Allison M, Zhang ZF, Watson KE, Chen L. Racial disparities of type 2[...]